Wednesday, March 28, 2018
12:00pm – 1:00pm
Yale School of Public Health – Winslow Auditorium 60 College Street, New Haven
Therapeutic and Economic Effects of Efficacy-Based Drug Withdrawals: The Drug Efficacy Study Initiative and its Manifold Legacies
Daniel Carpenter, who directs the social sciences program at the Radcliffe Institute, is the Allie S. Freed Professor of Government in the Faculty of Arts and Sciences at Harvard University. He combines theoretical, historical, statistical, and mathematical analyses to examine the development of political institutions, particularly in the United States, focusing on public bureaucracies and government regulation—particularly the regulation of health and financial products. Carpenter recently launched a long-term project examining petitioning in North American political development, comparing it to petitioning histories in Europe and India. Carpenter has held fellowships from the Brookings Institution, the Center for Advanced Study in the Behavioral Sciences, the John Simon Guggenheim Memorial Foundation, the Radcliffe Institute, and the Santa Fe Institute and received grants from the Alfred P. Sloan Foundation, the National Endowment for the Humanities, the National Science Foundation, the Robert Wood Johnson Foundation, the Russell Sage Foundation, and the Edmond J. Safra Center for Ethics. His book The Forging of Bureaucratic Autonomy: Reputations, Networks, and Policy Innovation in Executive Agencies, 1862–1928 (Princeton University Press, 2001) won the American Political Science Association’s Gladys M. Kammerer Award and the Charles H. Levine Memorial Book Prize of the International Political Science Association; and Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton University Press, 2010), the Allan Sharlin Memorial Award from the Social Science History Association. He received his doctorate in political science from the University of Chicago.
Co-Sponsored by the Collaboration for Research Integrity and Transparency (CRIT), Global Health Justice Partnership (GHJP), Yale School of Public Health (YSPH), and the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI).
Cosponsored panel, Battling Superbugs: Developing Legal and Policy Responses to Drug-Resistant Bacteria, Yale Law School, September 19, 2016 Presented at Clinical Trial Transparency and Reproducibility Discussion Panel and Workshop at NYU, September 29, 2016.
Cosponsored panel, Scientific Evidence in the Courtroom, Yale Law School, November 3, 2016